郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Characterization of methanthelinium binding and function at human M1-M5 muscarinic acetylcholine receptors.

期刊:Naunyn-Schmiedeberg's archives of pharmacology发表年份:2018作者:Matthias Irmen; Janine Holze; Theresa Bödefeld; Christian Tränkle

药效评价Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans.

期刊:The Journal of clinical investigation发表年份:2018作者:Peter Ulrichts; Antonio Guglietta; Torsten Dreier; Tonke van Bragt; Valérie Hanssens; Erik Hofman; Bernhardt Vankerckhoven; Peter Verheesen; Nicolas Ongenae; Valentina Lykhopiy; F Javier Enriquez; JunHaeng Cho; Raimund J Ober; E Sally Ward; Hans de H

药效评价Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivity.

期刊:Biochemical and biophysical research communications发表年份:2018作者:Kotaro Sakamoto; Ryokichi Koyama; Yusuke Kamada; Masanori Miwa; Akiyoshi Tani

药效评价Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic).

期刊:Journal of medicinal chemistry发表年份:2018作者:Pauline W Ondachi; Chad M Kormos; Scott P Runyon; James B Thomas; S Wayne Mascarella; Ann M Decker; Hernán A Navarro; Timothy R Fennell; Rodney W Snyder; F Ivy Carroll